Vanguard Group Inc Halozyme Therapeutics, Inc. Call Options Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding HALO
# of Institutions
543Shares Held
125MCall Options Held
294KPut Options Held
180K-
Black Rock Inc. New York, NY17.6MShares$805 Million0.02% of portfolio
-
State Street Corp Boston, MA6.63MShares$303 Million0.02% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.06MShares$186 Million5.07% of portfolio
-
Alliancebernstein L.P. New York, NY3.41MShares$156 Million0.07% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.13MShares$143 Million0.28% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $6.37B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...